Skip to contentL
Longevity Health Holdings, Inc.
L
XAGELongevity Health Holdings, Inc. Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$17.48K$17.48Kderivedno prior Q4 2023 on file Net Income-$914.28K-$914.28KderivedN/M vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Longevity Health Holdings, Inc. · CIK 1842939 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$16,254— Operating Incomederived-$1,006,877N/M Operating Cash Flowderived-$772,063N/M Margins · derivedGross margin93.0%
Operating margin-5760.5%
Net margin-5230.8%
ended Dec 31, 2024 · filed Mar 31, 2025 · 90 d after period end